Watch our event on Evidence and Controversies of Renal Denervation in 2025

You can now watch our event, held in collaboration with Medtronic, titled “Evidence and Controversies of Renal Denervation in 2025.”

The event featured international experts in renal denervation and highlighted the current evidence on this procedure. Additionally, an educational clinical case was presented, followed by an academic discussion addressing questions and concerns from the audience. The panel included Drs. Ricardo Costa (BRA), Fernanda Colombo (BRA), Fernando Cesena (BRA), and Ana Montenegro (COL) in this important one-hour event.

This event took place on September 11, 2024, and was attended by hundreds of live viewers. Watch it again now on our YouTube channel.

Evidence and Controversies of Renal Denervation in 2025


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

 

More articles by this author

March 26 – SOLACI Webinar: Evidence and Controversies in Renal Denervation in 2025

The Latin American Society of Interventional Cardiology invites you to a new virtual event supported by Medtronic. On this occasion, we will hold a 60-minute...

Uruguay Sessions 2025 | Young Interventional Cardiologists Contest

Call for Case Submission LI SOLACI Regional Sessions – 16° Southern Cone  It is with great pleasure that we hereby invite all young Latin American cardiologists...

Watch Angioplasty Techniques for Bifurcations Again From a Completely Different Perspective.

You can now watch on our YouTube channel the event we held in collaboration with Medtronic, titled: "Visualizations of Different PCI Techniques for Bifurcations...

2025 SOLACI Research Grant

By initiative of the board of directors (together with the research department), SOLACI is launching a research grant aimed at improving knowledge and access...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...